Social Determinants of Outcomes Disparity among Pediatric Patients with Solid Tumor

Elizabeth D Cochran1, Jillian C Jacobson1, Mithin Nehrubabu2

  • 1From the Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX (Cochran, Jacobson, Qiao, McCreery, Chung).

Insights

Socioeconomic factors like area deprivation index (ADI) significantly impact pediatric solid tumor outcomes. Higher ADI scores and minority racial status increase mortality risk, highlighting disparities in care.

Area of Science:

  • Pediatric Oncology
  • Health Services Research
  • Social Epidemiology

Background:

  • Socioeconomic factors significantly influence healthcare outcomes.
  • Area Deprivation Index (ADI) quantifies socioeconomic determinants of health.
  • Understanding these impacts is crucial for improving pediatric cancer care.

Purpose of the Study:

  • To assess the impact of socioeconomic factors on clinical outcomes in pediatric patients with solid tumors.
  • To identify specific social determinants of health associated with disparities in outcomes.
  • To inform targeted interventions for at-risk populations.

Main Methods:

  • Retrospective analysis of 3,863 pediatric solid tumor patients from the Texas Cancer Registry (1995-2019).
  • Utilized Area Deprivation Index (ADI) to measure socioeconomic status.
  • Employed logistic regression, linear regression, Cox proportional hazards regression, and Kaplan-Meier survival analysis.

Main Results:

  • Increased risk of death was associated with Black race, rare minority races, residence in border counties, and higher ADI scores.
  • Each one-point increase in ADI score correlated with a 4% rise in the 5-year risk of death.
  • Demographic breakdown: 53.5% male, average age 4.5 years; 47% White, 13.3% Black, 36.2% Hispanic, 1.7% Asian.

Conclusions:

  • Social determinants of health are linked to unequal outcomes in pediatric solid tumor patients.
  • Racial minorities and individuals in disadvantaged or border regions face higher mortality risks.
  • Findings can guide resource allocation and outreach strategies for vulnerable communities.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K